SECOND QUARTER FINANCIAL RESULTS
VANCOUVER, BC, Aug. 7, 2025 /CNW/ - "Wheaton delivered another outstanding quarter, achieving record revenue, adjusted net earnings, and operating cash...
MONTRÉAL, 07 août 2025 (GLOBE NEWSWIRE) -- Saputo inc. (TSX: SAP) (nous, Saputo ou la Société) a divulgué aujourd’hui ses résultats financiers pour le premier trimestre de l’exercice 2026, clos le 30 juin 2025. À moins d’avis contraire, tous les montants inclus dans ce communiqué de presse sont exprimés en millions de dollars canadiens (CAD), sauf les données par action, et sont présentés conformément aux Normes internationales d’information financière (IFRS).
VANCOUVER, BC, Aug. 7, 2025 /CNW/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX: SSL) has released its...
VANCOUVER, BC, Aug. 7, 2025 /PRNewswire/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX: SSL) has released its...
CHANDLER, Ariz., Aug. 7, 2025 /PRNewswire/ -- VIAVI (NASDAQ: VIAV) today reported results for its fiscal fourth quarter and fiscal year ended June 28,...
SAN BERNARDINO, Calif., Aug. 7, 2025 /PRNewswire/ -- Locksley Resources Ltd. (ASX: LKY; OTCQB: LKYRF) announced it has appointed Tribeca Capital Pte. Ltd. (Tribeca...
Financial and Business Highlights
Service revenue was $246.2 million for Q2 2025 and was $247.0 million for Q1 2025.Wavelength revenue increased by 27.2%, sequentially, and...
PERTH, Western Australia, Aug. 7, 2025 /CNW/ - Westgold Resources Limited (ASX: WGX) (TSX: WGX) - Westgold or the Company) advises that it has updated the following...
NEW ORLEANS, Aug. 06, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 12, 2025 to file lead plaintiff applications in a securities class action lawsuit against Tempus AI, Inc. (NasdaqGS: TEM), if they purchased the Company’s shares between August 6, 2024 and May 27, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of Illinois.
SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has priced its underwritten public offering of 20,895,522 shares of its common stock at a price to the public of $3.35 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 1,492,537 shares of common stock at a price to the public of $3.3499 per pre-funded warrant, which represents the per share public offering price of each share of common stock less the $0.0001 per share exercise price for each pre-funded warrant. All of the shares and pre-funded warrants are to be sold by Sana. In addition, Sana has granted the underwriters a 30-day option to purchase up to an additional 3,358,208 shares of its common stock. The gross proceeds from the offering are expected to be approximately $75.0 million before deducting underwriting discounts and commissions and other offering expenses and excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about August 8, 2025, subject to satisfaction of customary closing conditions.